Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Thurston Group-Backed ARC Health Acquires Dayspring Behavioral Health
ARC Health, a Thurston Group portfolio company, has announced the acquisition of Dayspring Behavioral Health. Dayspring Behavioral Health is a mental health practice with four locations throughout the Seattle MSA. Founded in 2012 by Dr. Amy Ford, the practice offers comprehensive counseling services and specialized pediatric neuropsychological assessments. ARC Health is a mental health specialty services organization supporting psychiatry, psychology and therapy providers in multiple locations throughout the United States. ARC was formed in 2021 in partnership with outpatient mental health provider Advanced Recovery Concepts. The company has more than 320 providers throughout its partner... Read More »
ABA Connect Acquires Colorado Springs-Based Bright Behavior
BrightPath Health Holdings, LLC, doing business as ABA Connect, has announced the completion of its acquisition of Colorado Springs-based Bright Behavior, LLC. According to the LevinPro HC database, this acquisition represents the 50th Behavioral Health Care transaction of the year and the seventh in the autism specialty. The deal marks ABA Connect’s entry into the state of Colorado. The combined company provides services to families throughout a network of 11 clinics across Texas and Colorado. Financial terms of the deal were not disclosed. Bright Behavior is an applied behavioral analysis (ABA) therapy facility in Colorado Springs that serves children diagnosed with autism and... Read More »
BV Investment Partners Announces Investment in Hardenbergh Group
Private equity firm BV Investment Partners has announced a growth-oriented investment in Hardenbergh Group, a provider of non-clinical professional staffing, consulting, physician peer review and outsourced solutions to healthcare organizations nationwide. Founded in 1991 by Mary Hardenbergh and based in Livonia, Michigan, Hardenbergh Group offers services in consulting and the interim staffing of medical services professionals and other non-clinical roles essential to patient safety, quality of care and other governance, risk and compliance requirements of leading healthcare organizations. BV Investment Partners is one of the oldest and most experienced sector-focused private equity firms... Read More »
Evergreen Nephrology Acquires Nephrology Associates of Central Florida
On August 15 Evergreen Nephrology, a portfolio company of Rubicon Founders, announced that it acquired Nephrology Associates of Central Florida for an undisclosed amount. Nephrology Associates of Central Florida is a full-service nephrology practice with nine locations across Central Florida. According to its website, the practice has 16 providers on staff. Evergreen Nephrology partners with nephrologists to provide the financial backing to take on increased cost of care risks associated with value-based care, which offers financial incentives to physicians, health systems and other providers based on quality of care. The new partnership will offer a multi-dimensional approach for people... Read More »
MB2 Dental Solutions Continues Acquisition Streak
MB2 Dental Solutions announced the purchase of four more dental practices; Spoonhower Orthodontics in Uniontown, Ohio; Saginaw and Frankenmuth, Michigan-based MI Journey Orthodontics; Parkway Smiles Dentistry in Woodbridge, Virginia; and Sturz and Abby Pediatric Dentistry and Orthodontics based out of Bakersfield, California. These acquisitions follow MB2 Dental’s acquisitions of Forest Hills Family Dentistry and Simon Dentistry, which were announced on August 11. MB2 Dental Solutions, a portfolio company of Charlesbank Capital Partners since February 2021, partners with dentists and specialists. Founded in 2007, MB2 offers general dentistry services, orthodontics, cosmetic dentistry and... Read More »
Private Equity: Acquisitions, Exits and the Future
Since private equity has grown significantly since 2010, private equity’s impact on the healthcare market is a topic that nobody seems to be able to talk about enough. From dominating the healthcare industry as buyers or partnering with health systems, PE has a hold on the healthcare landscape. And that’s showing up in the statistics. According to data captured in the LevinPro HC database, in 2010 4% of transactions were completed by PE buyers. That percentage inclined steadily for the next several years, jumping to 31% of 1,322 healthcare transactions in 2017, and to 39% of 2,234 healthcare deals in 2021. In 2022, private equity firms and their portfolio companies announced 963... Read More »
Dental Care Alliance Acquires Dental Health Associates of Virginia
Dental Care Alliance (DCA), a portfolio company of Harvest Partners, announced that it acquired Dental Health Associates of Virginia for an undisclosed price. Dental Health Associates offers full-service dental care with clinics in five Shenandoah Valley locations, Harrisonburg, Staunton, Dayton, Fishersville and Lexington, Virginia. According to its website, the practice is run by six providers. Founded in 1991 and headquartered in Sarasota, Florida, DCA is a multi-branded dental support organization with more than 400 affiliated dental offices and 900 dentists across 22 states. DCA’s allied practices represent all dental specialties and treat patients under over 150 brands. This... Read More »
Harmony Biosciences Holdings Acquires Zynerba Pharmaceuticals
On August 14, Harmony Biosciences Holdings, Inc. announced that it acquired Zynerba Pharmaceuticals, Inc. for $60 million. According to data captured in the LevinPro HC database, this transaction marks the 66th Pharmaceuticals acquisition of 2023. Zynerba Pharmaceuticals is a leader in innovative pharmaceutically produced, synthetic transdermal cannabidiol therapies for orphan neuropsychiatric disorders, including Fragile X syndrome. Zynerba’s lead asset, Zygel, is the first pharmaceutically manufactured, synthetic cannabidiol, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. Harmony Biosciences... Read More »
Swiftmerge Acquisition Corp. Takes HDL Therapeutics Public in $400 Million Transaction
On August 11, Swiftmerge Acquisition Corp., a West Vancouver-based special purpose acquisition company, announced that it was taking HDL Therapeutics Inc. public through a merger. HDL Therapeutics is a biotech innovator, focused on developing first-in-class treatments for intractable cardiovascular and neurovascular diseases using the company’s proprietary technology platform. The holders of the outstanding HDL Therapeutics preferred stock and common stock will receive a combination of cash and equity in Swiftmerge totaling $400 million. The business combination values the combined company at approximately $480 million. Upon closing of the merger, Swiftmerge will change its... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
